Some opportunities happen only once in a lifetime - like a job where you have the chance to change lives. At Alexion, people living with rare and devastating diseases are our Guiding Star. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. We value the uniqueness and diversity of our employees and recognize that nurturing the diverse perspectives and strengths of our people translates into innovative breakthroughs for patients.
Director, Nonclinical Toxicology
Head, Nonclinical Toxicology
An experienced toxicologist to manage toxicology programs designed to evaluate compounds in the Alexion pipeline.
An ability to work independently in a fast paced, dynamic and changing environment is essential.
Design and management of multiple simultaneous toxicology studies in rodents, non-rodents (e.g. dogs and rabbits) and non-human primates is required. Studies will be conducted exclusively at contract research organizations, and experience in managing CRO vendor relationships is essential.
Must have working knowledge of key regulatory guidance documents and the filing of reports with regulatory agencies in the US, Europe, and Japan (in collaboration with key regulatory personnel), and experience in writing and submission of regulatory documents. Support for processes related to compound registration is also essential.
The Director will manage every aspect of the study process, including budget, execution and troubleshooting, data analysis, and report writing.
Membership and effective contributions to multidisciplinary project teams is required. As required, the Director may be a member of or make presentations to senior level management committees such as RSC, FIH and/or DCSC.
The Director will also be responsible for participation on multiple business diligence/due diligence and external collaborations, experience in evaluating business development opportunities from safety and nonclinical perspective is highly preferred.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion has taken critical steps to protect colleagues, loved ones, and patients from COVID-19 and its variants. All US-based employees must comply with Alexion's COVID-19 vaccination mandate. Alexion provides exceptions based on applicable state law as well as reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding a legally required exemption or accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.
As a leading employer in our industry, Alexion offers a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, and much more.
AstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. If you're interested in career opportunities with AstraZeneca, click here.Read Full Description